Clinical Trials Browser

Completed × Prostatic Neoplasms × Eflornithine × Clear all

NCT00006101 2018-05-14

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Phase 2 Completed

76 enrolled 7 charts

Prostatic Neoplasms